Takeda Pharmaceutical Company Ltd

🇸🇪Sweden

Country: 🇸🇪Sweden

Ownership: -

Established: 1925-01-01

Employees: -

Market Cap: $47.5B

Website: http://www.takeda.co.jp/

Clinical Trials

A Study of TAK-662 for Japanese Patients With Congenital Protein C Deficiency

Phase 1

Completed

Conditions: Congenital Protein C Deficiency

Interventions: Drug: TAK-662

First Posted Date: 2021-08-02

Last Posted Date: 2024-11-21

Lead Sponsor: Takeda

Target Recruit Count: 5

Registration Number: NCT04984889

Locations: 🇯🇵
Chiba Children's Hospital, Chiba, Japan
🇯🇵
Nara Medical University Hospital, Kashihara, Nara, Japan
🇯🇵
Chiba University Hospital, Chiba, Japan

and more 1 locations

A Study of Real Life Treatment for Multiple Myeloma (MM)

Recruiting

Conditions: Multiple Myeloma

First Posted Date: 2021-08-02

Last Posted Date: 2024-02-16

Lead Sponsor: Takeda

Target Recruit Count: 111

Registration Number: NCT04985643

Locations: 🇷🇺
Altai Regional Clinical Hospital, Barnaul, Altay Region, Russian Federation
🇷🇺
Bryansk Regional Hospital No. 1, Bryansk, Bryansk Region, Russian Federation
🇷🇺
Kaluga Regional Clinical Hospital, Kaluga, Central Federal District, Russian Federation

and more 22 locations

A Study for Post-Marketing Surveillance of Nesina® Tablet Monotherapy or Combination Therapy in Participants With Type 2 Diabetes (T2DM) in South Korea

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Alogliptin Benzoate

First Posted Date: 2021-07-28

Last Posted Date: 2022-04-05

Lead Sponsor: Takeda

Target Recruit Count: 3623

Registration Number: NCT04980040

A Post-Marketing Surveillance Study on NesinaAct® Tablet Use Among Type 2 Diabetes Mellitus Participants in Korea

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: NesinaAct® Tablet

First Posted Date: 2021-07-28

Last Posted Date: 2022-03-07

Lead Sponsor: Takeda

Target Recruit Count: 730

Registration Number: NCT04980014

A Study of REPLAGAL® in Treatment-naive Chinese Participants With Fabry Disease

Phase 3

Completed

Conditions: Fabry Disease

Interventions: Biological: REPLAGAL

First Posted Date: 2021-07-23

Last Posted Date: 2024-10-07

Lead Sponsor: Takeda

Target Recruit Count: 20

Registration Number: NCT04974749

Locations: 🇨🇳
Xiangya Hospital, Central South University, Changsha, China
🇨🇳
The Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China
🇨🇳
Shandong Provincial Hospital, Jinan, China

and more 3 locations

A Study to Check How Often People Treated With Darvadstrocel for Crohn's Disease Are Diagnosed With Cancer

Active, not recruiting

Conditions: Crohn Disease
Complex Perianal Fistula

First Posted Date: 2021-07-21

Last Posted Date: 2024-07-23

Lead Sponsor: Takeda

Target Recruit Count: 5850

Registration Number: NCT04971525

Locations: 🇫🇷
1. Système National des Données de Santé (SNDS), Charenton-le-Pont, France
🇳🇱
PHARMO, Utrecht, Netherlands
🇪🇸
Estudio Nacional en Enfermedad Inflamatoria intestinal sobre Determinantes genéticos y Ambientales (ENEIDA), Madrid, Spain

and more 1 locations

A Study of TAK-105 in Healthy Adults

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: TAK-105-a Placebo
Drug: TAK-105-a

First Posted Date: 2021-07-16

Last Posted Date: 2024-08-02

Lead Sponsor: Takeda

Target Recruit Count: 80

Registration Number: NCT04964258

Locations: 🇺🇸
Celerion, Tempe, Arizona, United States
🇺🇸
PPD Development, LP, Austin, Texas, United States

A Study to Assess Maternal and Fetal Outcomes After Taking Prucalopride During Pregnancy

Active, not recruiting

Conditions: Constipation
Pregnancy

Interventions: Other: No Intervention

First Posted Date: 2021-07-14

Last Posted Date: 2024-03-15

Lead Sponsor: Takeda

Target Recruit Count: 100

Registration Number: NCT04961840

Locations: 🇺🇸
Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States

A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)

Completed

Conditions: Colitis, Ulcerative
Inflammatory Bowel Diseases
Crohns Disease

First Posted Date: 2021-07-13

Last Posted Date: 2024-08-06

Lead Sponsor: Takeda

Target Recruit Count: 185

Registration Number: NCT04959851

Locations: 🇧🇪
Erasme, Bruxelles, Belgium
🇧🇪
CHWAPI, Tournai, Belgium
🇧🇪
UZA, Antwerpen, Belgium

and more 7 locations

A Study of the Burden of Illness and Treatment Patterns in Teenagers and Adults With Hereditary Angioedema

Completed

Conditions: Hereditary Angioedema

First Posted Date: 2021-07-12

Last Posted Date: 2023-06-26

Lead Sponsor: Takeda

Target Recruit Count: 221

Registration Number: NCT04957641

Locations: 🇨🇦
Vancouver Allergy Clinic, Vancouver, British Columbia, Canada
🇬🇷
Navy Hospital of Athens, Athens, Greece
🇨🇿
Fakultni nemocnice v Motole, Praha, Czechia

and more 33 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy